No Detail Found!

High flow nasal cannula to prevent intubation in obese patient with COVID-19 induced ARDS: a case report

Author(s)
Ni Made Ayu Suria Mariati Department of Anesthesiology & Intensive Care, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.; Department of Anesthesiology & Intensive Care, Faculty of Medicine, University of Mataram-West Nusa Tenggara General Hospital, Lombok, Indonesia
Adhrie Sugiarto Department of Anesthesiology & Intensive Care, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
Elya Endriani Department of Anesthesiology & Intensive Care, Faculty of Medicine, University of Mataram-West Nusa Tenggara General Hospital, Lombok, Indonesia
Rina Lestari Department, Faculty of Medicine, University of Mataram-West Nusa Tenggara General Hospital, Lombok, Indonesia
Karina Anindita Department of Internal Medicine, Siloam Hospitals Mataram, Jl. Majapahit, Pagesangan, Kec. Mataram, Kota Mataram, Nusa Tenggara Bar. 83115, Indonesia.
Abstract
Obese patients have been identified to have a poor prognosis and a higher risk of death from coronavirus disease2019 (COVID-19). We present reports of two obese patients infected with COVID-19 with acute respiratory distress syndrome (ARDS) who showed improvement with high flow nasal cannula (HFNC). HFNC is a noninvasive oxygen delivery device which is capable of delivering a high concentration of oxygen that can reduce the requirement for tracheal intubation. HFNC is convenient to use, can reduce dyspnea without effecting the length of stay in ICU in these cases; and has a high merit to be used in selected patients requiring oxygen before attempting intubation and mechanical ventilation.
Publication Details
Page(s) 212-216
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 25, Issue: 2, Year: 2021

Request the full text from PASTIC

Keywords
COVID-19, ARDS, Obese, High flow nasal cannula, HFNC
0

Citations

0

Downloads

33

Views